These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9848000)

  • 1. Guillain-Barré syndrome, CIDP and other chronic immune-mediated neuropathies.
    Hartung HP; van der Meché FG; Pollard JD
    Curr Opin Neurol; 1998 Oct; 11(5):497-513. PubMed ID: 9848000
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Maimone D; Annunziata P; Simone IL; Livrea P; Guazzi GC
    J Neuroimmunol; 1993 Aug; 47(1):55-61. PubMed ID: 8376548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
    Hartung HP; Reiners K; Schmidt B; Stoll G; Toyka KV
    Ann Neurol; 1991 Jul; 30(1):48-53. PubMed ID: 1929228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum levels of endothelial leukocyte adhesion molecules in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Oka N; Akiguchi I; Kawasaki T; Ohnishi K; Kimura J
    Ann Neurol; 1994 May; 35(5):621-4. PubMed ID: 7513983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatigue in immune-mediated neuropathies.
    Merkies IS; Faber CG
    Neuromuscul Disord; 2012 Dec; 22 Suppl 3():S203-7. PubMed ID: 23182640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage responses in inflammatory demyelinating neuropathies.
    Griffin JW; Stoll G; Li CY; Tyor W; Cornblath DR
    Ann Neurol; 1990; 27 Suppl():S64-8. PubMed ID: 2194430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental immunology of Guillain-Barré syndrome.
    Abramsky O; Steiner I
    Int J Neurol; 1981; 15(3-4):301-13. PubMed ID: 6927600
    [No Abstract]   [Full Text] [Related]  

  • 8. Demyelinating inflammatory neuropathies, including Guillain-Barré syndrome.
    Steck AJ; Schaeren-Wiemers N; Hartung HP
    Curr Opin Neurol; 1998 Aug; 11(4):311-8. PubMed ID: 9725076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gm haplotypes in inflammatory demyelinating polyneuropathies.
    Feeney DJ; Pollard JD; McLeod JG; Stewart GJ; De Lange GG
    Ann Neurol; 1989 Dec; 26(6):790-2. PubMed ID: 2557797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: pathogenesis and treatment.
    Koski CL
    Semin Neurol; 1994 Jun; 14(2):123-30. PubMed ID: 7984827
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy.
    van Doorn PA; Brand A; Vermeulen M
    Neurology; 1987 Nov; 37(11):1798-802. PubMed ID: 3670618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell responses to myelin proteins in Guillain-Barré syndrome.
    Khalili-Shirazi A; Hughes RA; Brostoff SW; Linington C; Gregson N
    J Neurol Sci; 1992 Sep; 111(2):200-3. PubMed ID: 1279128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy.
    Leppert D; Hughes P; Huber S; Erne B; Grygar C; Said G; Miller KM; Steck AJ; Probst A; Fuhr P
    Neurology; 1999 Jul; 53(1):62-70. PubMed ID: 10408538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.
    van der Meché FG; van Doorn PA
    Ann Neurol; 1995 May; 37 Suppl 1():S14-31. PubMed ID: 8968214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization and risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Choudhary PP; Osborn M; Rees JH; Sanders EA
    Muscle Nerve; 1996 Sep; 19(9):1230-1. PubMed ID: 8761286
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum antibodies to GM1 and GM3-gangliosides in systemic lupus erythematosus with chronic inflammatory demyelinating polyradiculoneuropathy.
    Sindern E; Stark E; Haas J; Steck AJ
    Acta Neurol Scand; 1991 Jun; 83(6):399-402. PubMed ID: 1887763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy.
    Schmidt B; Toyka KV; Kiefer R; Full J; Hartung HP; Pollard J
    Muscle Nerve; 1996 Apr; 19(4):474-87. PubMed ID: 8622727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive transfer studies in Guillain-Barré polyneuropathy.
    Feasby TE; Hahn AF; Gilbert JJ
    Neurology; 1982 Oct; 32(10):1159-67. PubMed ID: 6889701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased frequencies of HPRT mutant T lymphocytes in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: further evidence for a role of T cells in the etiopathogenesis of peripheral demyelinating diseases.
    Van den Berg LH; Mollee I; Wokke JH; Logtenberg T
    J Neuroimmunol; 1995 Apr; 58(1):37-42. PubMed ID: 7730448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired demyelinating neuropathies.
    Zito G; Cook SD; Dowling PC
    Int J Neurol; 1981; 15(3-4):254-65. PubMed ID: 6765480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.